During the past decade, General Hospital Karlovac conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 8 clinical trials were completed, i.e. on average, 160% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "General Hospital Karlovac" #1 sponsor was "Shire" with 3 trials, followed by "Pfizer" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "KRKA" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "General Hospital Karlovac" #1 collaborator was "3ARH" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator and "INTERBORA" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "General Hospital Karlovac" are "Ulcerative Colitis" (3 trials), "Diabetes Mellitus, Type 2" (2 trials), "Rheumatoid Arthritis" (2 trials), "Breast Neoplasms" (1 trials) and "Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "General Hospital Karlovac" in a lesser frequency.

Most popular intervention types in "General Hospital Karlovac" are "Drug" (11 trials), "Other" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ontamalimab" (2 trials), "Pregabalin" (2 trials), "1.25 g PA21 (250 mg iron)" (1 trials) and "10.0 g PA21 (2,000 mg iron)" (1 trials). Other intervention names were less common.

The vast majority of trials in "General Hospital Karlovac" are 12 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "General Hospital Karlovac". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in General Hospital Karlovac, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in General Hospital Karlovac, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".